Core Points - The board of directors of Fujian Wancheng Biotechnology Group Co., Ltd. held its 33rd meeting on September 2, 2025, to discuss various resolutions [1] - The board approved the nomination of Ms. Yang Fan as an independent director candidate, pending approval from the shareholders' meeting [2] - The board also approved the appointment of Mr. You Zilin as the company secretary and the designation of Mr. Wang Zenin and Mr. You Zilin as authorized representatives for the company in compliance with Hong Kong Listing Rules [2] - A report on the usage of previously raised funds was approved, covering the period up to June 30, 2025, and was reviewed by an external accounting firm [2] - The board agreed to establish internal governance systems to enhance company operations and compliance with relevant laws and regulations [2][4] - The company plans to hold its third extraordinary shareholders' meeting on September 18, 2025, to discuss the aforementioned resolutions [4]
万辰集团: 第四届董事会第三十三次会议决议公告